Mylan Expects Competition From Duragesic “Authorized” Generic In January

Mylan’s guidance assumes a Jan. 24 launch of its fentanyl generic “with at least one competitor in the market.” Watson says it anticipates a 2005 launch for its generic.

More from Archive

More from Pink Sheet